The Trump administration rolled out its new prescription drug platform — TrumpRx — with the promise of saving Americans money.
But congressional Democrats have a new warning: The website directs Americans to brand-name drugs rather than generics, meaning consumers are frequently at risk of paying more than they should — in some cases, thousands of dollars annually.
In a new report shared first with MS NOW, Democrats on the Joint Economic Committee analyzed the prices of 15 common medications, comparing the discounted prices on the TrumpRx website to the cost of generics purchased using a GoodRx coupon.
The report shows, for instance, that a year’s supply of the Afib medication Tikosyn, purchased at the TrumpRx discounted rate, would cost about $4,000. By contrast, according to the report, a generic version of the drug bought with a GoodRx coupon would cost just shy of $200 annually — a savings of roughly $3,800. (The report uses Manchester, N.H., as the location for the GoodRx search.)
For Pristiq, used to treat depression, the TrumpRx platform’s discounted rate clocks in around $2,400 for an annual supply. Generics purchased with a GoodRx coupon would cost consumers about $320 for the year — a savings of more than $2,000 annually.
In a statement, New Hampshire Sen. Maggie Hassan, the top Democrat on the Joint Economic Committee, argued that “TrumpRx directs families to buy expensive brand-name drugs when generic versions are available elsewhere at a fraction of the cost.”
Hassan accused the Trump administration of helping “Big Pharma line its pockets.” She encouraged the White House and Republicans to work with Democrats “to actually lower prescription drug costs.”
President Donald Trump formally rolled out the TrumpRx website last week, telling Americans they were “going to save a fortune.”
The new online platform connects consumers with drugmakers’ direct-to-consumer websites to purchase medications at reduced rates, and also offers coupons to use at brick and mortar pharmacies.
Those lower costs, Trump said, are made possible by the deals his administration has made with pharmaceutical companies to match the prices in other developed nations — his so-called “most favored nations” pricing.
The TrumpRx website initially launched with 40 drugs, with the promise to add more. And the discounted prices, the website says, are only available for “cash-paying patients” — not those using insurance.
Appearing on MS NOW to mark the website’s rollout, Marty Markary, the commissioner of the Food and Drug Administration, described the TrumpRx launch as “the beginning of a new chapter in American health care, where, for the first time, you can buy the drug from those who make it.”









